DENTSPLY SIRONA (NASDAQ:XRAY) Issues Quarterly Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAY) announced its earnings results on Thursday. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02, Briefing.com reports. The company had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company’s revenue was up .4% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 EPS. DENTSPLY SIRONA updated its FY 2024 guidance to 1.820-1.860 EPS and its FY24 guidance to $1.82-$1.86 EPS.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded up $0.60 during mid-day trading on Friday, hitting $17.86. 9,385,798 shares of the company’s stock traded hands, compared to its average volume of 3,107,804. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The firm has a 50 day moving average of $24.82 and a two-hundred day moving average of $25.98. The firm has a market capitalization of $3.62 billion, a price-to-earnings ratio of -8.63, a price-to-earnings-growth ratio of 1.31 and a beta of 1.02. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.60.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Barrington Research reduced their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday. Needham & Company LLC reduced their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Evercore ISI dropped their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Finally, Robert W. Baird lowered their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $29.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.